🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCagriSema (amylin + semaglutide) — REDEFINE Phase 3 results Page 4

CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results

Dr.Martinez Thu, Mar 12, 2026 at 10:19 AM 20 replies 606 viewsPage 4 of 4
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Mar 12, 2026 at 3:59 PM#16

Just wanted to say — for anyone reading this CagriSema (amylin + thread who is feeling discouraged: it gets better. The first 6 weeks are the hardest. Hang in there. 💪

31 1Dr.LeslieOBGYN, MikeNYC_runner and 28 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Mar 12, 2026 at 4:16 PM#17

As a pharmacist, I want to add some clinical context to this discussion on CagriSema (amylin + semaglutide) .

Building on what TomTeleRx said — the evidence base here is robust. The key publications to reference are from the SELECT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
37 17tommy_boulder, hyun_seoul, jim_asheville and 34 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Mar 12, 2026 at 4:33 PM#18
VanRx_Mike said:
The first 6 weeks are the hardest

Gonna push back on this one. CagriSema (amylin + semaglutide) is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.

Last edited: Mar 12, 2026 at 7:33 PM
36 2PharmHunterJen, TomTeleRx, DoseLogDan and 33 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Mar 12, 2026 at 4:50 PM#19

Subscribing to this thread. CagriSema (amylin + is exactly what I've been researching. 🙏

Last edited: Mar 12, 2026 at 10:50 PM
6 22BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 3 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Mar 12, 2026 at 5:07 PM#20

Reading this thread on CagriSema (amylin + hits close to home. Night shift nurse — I started at 291 lbs and felt like I would tried everything.

7 months on tirz and I am a different person. Not just the 66 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about CagriSema (amylin + — take the leap. It was the best health decision I have ever made. ❤️

21 8Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 18 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
Survodutide (GCG/GLP-1) — MASH and obesity trial results16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register